SCHEMBL7962020

SCHEMBL7962020

CCCOc1ccc(OC)cc1C(=N)N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 7/20 0.47
MTNR1A P48039 2/20 0.45
MTNR1B P49286 2/20 0.45
PRSS2 P07478 2/20 0.42
PRSS3 P35030 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CLK1 P49759 1/20 0.41
MAPT P10636 3/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11629258 0.98 PRSS1 (0.48) PRSS1MTNR1AMTNR1BPRSS2PRSS3
Hydrochloric Acid SCHEMBL7960433 0.88 ALDH1A1 (0.47) PRSS1MTNR1AMTNR1BPRSS2PRSS3
Hydrochloric Acid SCHEMBL11632488 0.86 PRSS1 (0.47) PRSS1MTNR1AMTNR1BPRSS2PRSS3
SCHEMBL7950657 0.85 MTNR1A (0.51) MTNR1AMTNR1BKDM4ENPC1LMNA
SCHEMBL2567834 0.84 KDM4E (0.44) PRSS1KDM4EHPGDNPC1LMNA
SCHEMBL16952978 0.83 MTNR1A (0.51) MTNR1AMTNR1BKDM4EHPGDLMNA
SCHEMBL2562274 0.81 PRSS1 (0.57) PRSS1
Hydrochloric Acid SCHEMBL11629723 0.80 CA12 (0.55) PRSS1PRSS2PRSS3HPGDRAB9A
SCHEMBL7962802 0.80 HTR2C (0.46) PRSS1KDM4EHPGDNPC1LMNA
SCHEMBL7961007 0.80 HTR2B (0.46) PRSS1KDM4EHPGDNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed